Population Pharmacokinetics of Tigecycline in Patients Treated With ECMO

Tigecycline is a commonly used antibiotic in critically ill patients. The pharmacokinetics (PK) of tigecycline in intensive care unit (ICU) patients can be affected by severe pathophysiological changes so that standard dosing might not be adequate. At present, a number of studies have reported that ECMO will affect the PK of anti-infective drugs and lead to treatment failure. The purpose of this study was to describe the population PK of tigecycline in patients treated with ECMO and to evaluate the relationship between individual PK parameters and patient covariates.

Population Pharmacokinetics of Tigecycline in Patients Treated With ECMO

Recruitment

Summary

Participation Requirements

Description

Tracking Information